 |
 |
|
|
||
      |
||
|
||
 |
|
|
|
|
|
||||
|
Mark DuVal
David Teicher |
Mark DuVal is Director and Managing Partner of DuVal & Associates, where he counsels pharmaceutical, medical device, biotech, food and nutritional supplement companies. Having worked extensively with drug delivery systems businesses, Mr. DuVal’s practice also includes combination products, specifically drugs and devices as well as biologics and devices. He regularly advises clients in all areas of FDA laws and regulations, from product development to post-marketing responsibilities. Mr. DuVal counsels a wide range of medical device and pharmaceutical companies on sales and marketing programs that are appropriately aggressive, yet compliant. Prior to founding DuVal & Associates, PA, Mr. DuVal was general counsel for the 3M Pharmaceuticals and Drug Delivery Systems businesses for almost fifteen years. He also worked in the United Kingdom on a Pan-European assignment as general counsel for 3M Health Care, Limited. Upon returning from Europe, Mr. DuVal was recruited by Medtronic, where he worked in Corporate Regulatory Compliance Services. While at Medtronic, Mr. DuVal was responsible for antitrust and FDA advice for business unit lawyers and their clients. Mr. DuVal is a member of the following associations: Minnesota State and Hennepin Country Bar Associations; the Medical Devices Committee of The Food and Drug Law Institute (FDLI), Wash.,D.C.; Medical Alley; Mayor Randy Kelly’s City of St. Paul Biotech Advisory Committee; and Governor Tim Pawlenty’s Minnesota Biosciences Council. Mr. DuVal was previously a member of the following: PhRMA Law Section, Executive Committee (1987–2001); Board of Advisors, Food & Drug Law Institute (FDLI) (1996–2001), Wash. D.C.; Food and Drug Law Committee, Minnesota State Bar Association; and a member of the Rand Corporation group which studied pharmaceutical and medical device product liability. Mr. DuVal received his Juris doctor degree, with honors, from the William Mitchell College of Law, where he was the executive editor at the Law Review and a student Bar Association Representative. He received his bachelor of science degree in public administration, with honors, from St. Cloud State University. Mr. DuVal is also a frequent speaker and author of articles and papers addressing FDA topics.
David Teicher is an associate attorney with DuVal and Associates where he counsels medical device and pharmaceutical companies in many US FDA related matters. Mr. Teicher has a nearly thirty year career specializing in FDA regulatory affairs. He started as an investigator biomedical engineer in the FDA's Los Angeles and Minneapolis District Offices where he conducted approximately 300 factory quality assurance audits of medical device manufacturers in the US and internationally including manufacturers of cardiac pacemakers, mechanical heart valves, angioplasty catheters, dialysis membranes, intraocular lenses, and anesthesia and respiratory care equipment. After eleven years, Mr. Teicher moved to the corporate sector to work in a variety of regulatory affairs, quality assurance, and clinical affairs positions for venture capital backed start-ups and at small and mid-sized medical device companies. These included manufacturers of peripheral and coronary stents, drug delivery catheters, coronary perfusion equipment, emboli collection catheters, cardiac pacemakers, software controlled coronary mapping equipment, and in vitro diagnostics. Mr. Teicher received his juris doctor from William Mitchell College of Law while working for the FDA. He also has a Master of Science in Biomedical Engineering from the University of Southern California and a Bachelor of Science in Biology from San Diego State University. He is an adjunct assistant professor at St. Cloud State University teaching the introductory course “Legal Basis for Medical Device Regulation” for their new Master of Science degree in Regulatory Affairs and Services program. |
|
||||||
|
|
|||||||
|
||||||||
